Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-To-Moderate Alzheimer's Disease”

382 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 382 results

Testing effectiveness (Phase 2)Study completedNCT00742417
What this trial is testing

Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 42
Early research (Phase 1)Study completedNCT00733642
What this trial is testing

Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 15
Large-scale testing (Phase 3)Study completedNCT01741194
What this trial is testing

AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext

Who this might be right for
Alzheimer's Disease
Cerecin 418
Post-approval studies (Phase 4)Study completedNCT00505167
What this trial is testing

Memantine Versus Donepezil in Early Stages of Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
Hospital Miguel Servet 64
Not applicableLooking for participantsNCT04124029
What this trial is testing

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Who this might be right for
Mild Traumatic Brain InjuryModerate Traumatic Brain InjuryMild Cognitive Impairment
VA Office of Research and Development 800
Large-scale testing (Phase 3)Ended earlyNCT05026177
What this trial is testing

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,125
Testing effectiveness (Phase 2)UnknownNCT06096090
What this trial is testing

Phase II Clinical Trial of Interleukin-2 in AD

Who this might be right for
Alzheimer Disease
The Methodist Hospital Research Institute 40
Early research (Phase 1)Study completedNCT00411580
What this trial is testing

Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 58
Not applicableStudy completedNCT05527288
What this trial is testing

A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population

Who this might be right for
Alzheimer DiseaseDementiaBrain Diseases+6 more
Sinotau Pharmaceutical Group 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07178678
What this trial is testing

Evaluation of the Safety and Efficacy of NeuroEPO in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Mild Alzheimer's DiseaseModerate Alzheimer's Disease
University of Saskatchewan 90
Large-scale testing (Phase 3)Ended earlyNCT00550420
What this trial is testing

Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 331
Early research (Phase 1)Study completedNCT00495417
What this trial is testing

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Affiris AG 24
Testing effectiveness (Phase 2)Study completedNCT04070378
What this trial is testing

Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Marc L Gordon, MD 16
Large-scale testing (Phase 3)Study completedNCT00506415
What this trial is testing

Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm^2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline

Who this might be right for
Alzheimer Disease
Novartis Pharmaceuticals 1,584
Testing effectiveness (Phase 2)Study completedNCT01073228
What this trial is testing

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseCentral Nervous System DiseasesCognition
FORUM Pharmaceuticals Inc 409
Post-approval studies (Phase 4)Study completedNCT02703636
What this trial is testing

NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.

Who this might be right for
Mild to Moderate Alzheimer's Disease
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT01354691
What this trial is testing

Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementiaMemory Loss+1 more
Avraham Pharmaceuticals Ltd 200
Testing effectiveness (Phase 2)Ended earlyNCT00606476
What this trial is testing

AAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
JANSSEN Alzheimer Immunotherapy Research & Development, LLC 194
Large-scale testing (Phase 3)Ended earlyNCT05575076
What this trial is testing

Open-label Extension for Phase 3 Clinical Trials of Simufilam

Who this might be right for
Alzheimer Disease
Cassava Sciences, Inc. 1,081
Testing effectiveness (Phase 2)Study completedNCT02947893
What this trial is testing

Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Georgetown University 37
Next Page